86 related articles for article (PubMed ID: 12215762)
21. Argatroban in HIT type II and acute coronary syndrome.
Lewis BE; Walenga JM
Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():46-55. PubMed ID: 12811012
[TBL] [Abstract][Full Text] [Related]
22. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Kondo LM; Wittkowsky AK; Wiggins BS
Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of argatroban.
Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
[TBL] [Abstract][Full Text] [Related]
24. [Argatroban: pharmacological properties and anaesthesiological aspects].
Kleinschmidt S; Stephan B; Pindur G; Bauer C
Anaesthesist; 2006 Apr; 55(4):443-50. PubMed ID: 16389543
[TBL] [Abstract][Full Text] [Related]
25. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications.
Chen JL
Heart Dis; 2001; 3(3):189-98. PubMed ID: 11975790
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule direct antithrombins: argatroban.
Fareed J; Jeske WP
Best Pract Res Clin Haematol; 2004 Mar; 17(1):127-38. PubMed ID: 15171962
[TBL] [Abstract][Full Text] [Related]
27. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
Dhillon S
Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
[TBL] [Abstract][Full Text] [Related]
28. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ; Soffer J
Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
[TBL] [Abstract][Full Text] [Related]
29. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
30. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
Matsuo T; Koide M; Kario K
Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
[TBL] [Abstract][Full Text] [Related]
31. Argatroban in the management of heparin-induced thrombocytopenia.
Babuin L; Pengo V
Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Lewis BE; Walenga JM; Wallis DE
Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
[TBL] [Abstract][Full Text] [Related]
33. Argatroban.
Kathiresan S; Shiomura J; Jang IK
J Thromb Thrombolysis; 2002 Feb; 13(1):41-7. PubMed ID: 11994559
[TBL] [Abstract][Full Text] [Related]
34. Argatroban.
McKeage K; Plosker GL
Drugs; 2001; 61(4):515-22; discussion 523-4. PubMed ID: 11324681
[TBL] [Abstract][Full Text] [Related]
35. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Warkentin TE
Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
[TBL] [Abstract][Full Text] [Related]
36. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
37. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
LaMonte MP; Brown PM; Hursting MJ
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
Cruz-González I; López-Jiménez R; Perez-Rivera A; Yan BP
Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1483-93. PubMed ID: 22970706
[TBL] [Abstract][Full Text] [Related]
39. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
Van Cott EM; Roberts AJ; Dager WE
Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
[TBL] [Abstract][Full Text] [Related]
40. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
Matsuo T; Koide M; Kario K
Artif Organs; 1997 Sep; 21(9):1035-8. PubMed ID: 9288875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
